|
Delcath Systems Incorporated - Company Profile Snapshot
| Company Profile: |
Delcath Systems Incorporated |
| Ticker: |
DCTH |
| Exchanges: |
NAS |
| 2008 Sales: |
n/a |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
UNITED STATES |
| Employees: |
6 |
Business Description
Delcath Systems Incorporated. The Company's principal activities are developing and marketing a proprietary drug delivery system. This system is capable of introducing and removing high dose chemotherapy agents to a diseased organ system while greatly inhibiting their entry into the general circulation system. The Company has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. The Company is in the development stage and conducts clinical trials designed to secure marketing approval for the system in the United States. The Delcath system kit includes the following disposable components: Infusion catheter, Double balloon catheter, Extracorporeal filtration circuit, Filters and Return catheter.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
